Five hundred sixty-eight foreign companies and their U.S. subsidiaries or affiliates have reported spending $363 million so far in the 2011-2012 cycle on U.S. lobbying of Congress or the executive branch, PAC contributions to federal candidates, and donations to IRS Section 527 organizations. Spending in the full first quarter of 2012 will be filed in mid-April. These companies appear to be on track to equal their $707 million spending in the previous full two-year cycle, 2009-1010.
Five hundred forty-six of these companies have spent $334 million on federal lobbying. The leading companies include Royal Dutch Shell Group/Netherlands $14.6 million; Merck KGaA/Germany $11 million; BP Plc/United Kingdom $8.5 million; Sanofi-Aventis/France $6.9 million; Bayer AG/Germany $6.7 million.
One hundred fifty-six of these companies have U.S. subsidiaries or affiliates with federal PACs. So far this cycle, through the end of February, the PACs have donated almost $21 million to federal candidates. The leading PACs include those of Deloitte Touche Tohmatsu/United Kingdom $1.7 million; PricewaterhouseCoopers/United Kingdom $1.6 million; Merck KGaA/Germany $1.1 million; BearingPoint Europe Holdings BV/Netherlands $885,900; Astrazeneca Plc/United Kingdom $838,500.
Fify-nine of these companies have donated almost $4.8 million to IRS Section 527 organizations. Leading companies include Astrazeneca Plc/United Kingdom $555,000; GlaxoSmithKline Plc/United Kingdom $500,000; Novartis AG/Switzerland $380,000; Novo Nordisk A/S /Denmark $365,000; Anheuser-Busch InBev/Belgium $320,000.
Use the Cash Register on the left menu to view all foreign companies and their rankings of dollar politics activity in the U.S.
During recent legislative debate of the Disclose Act, a provision was removed that would have banned U.S. companies that are subsidiaries or affiliates of foreign companies from operating federal PACs.
No comments:
Post a Comment